Modern disease modifying drugs in rheumatoid arthritis in the perioperative period: Patients with rheumatic diseases under therapy with methotrexate, Leflunomide or TNF-alpha blockers in the perioperative period;Moderne rheumatische basistherapie perioperativ: Patienten des rheumatischen formenkreises unter therapie mit methotrexat, Leflunomid bzw. TNF-alpha-blockern perioperativ

Aktuelle Rheumatologie

Volumn 32, Issue 2, 2007, Pages 74-77

  Rehart, Stefan ^a   Petak, N ^a  

^a Chefarzt der Klinik fur Orthopadie und Unfallchirurgie   (Germany)

Author keywords

Biologicals; DMARDs; Modern antirheumatic therapy; Perioperative management; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RHEUMATOID ARTHRITIS; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 34248385153     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963081     Document Type: Article

References (11)

1. Arnett FC et al. The American Rheumatism Association 1987. Revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988; 31 (3): 315-324
2. Bibbo C, Goldberg JW. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot & Ankle International 2004; 25 (5): 331-335
3. Bridges SL Jr, López-Méndez A, Han KH et al. Should Methotrexat be discontinued before elective orthopaedic surgery in patients with rheumatoid arthritis? J Rheumatology 1991; 18: 984-988
4. Giles JT, Gelber AC, Nanda S et al. TNF inhibitor therapy increases the risk of post-operative orthopaedic infection in patients with rheumatoid arthritis. American College of Rheumatology 2004 meeting, San Antonio, 16-21.10.2004. 2004: Abstract 1764
5. Grennan DM, Gray J, Loudon J et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001; 60: 214-217
6. Jain A et al. Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data. Ann Rheum Dis 2004; 63: 602-603
7. Keysser M, Keysser C, Neumann S et al. Wundinfektionen nach rheumachirugischen Eingriffen und ihre Beziehung zur präoperativen Basistherapie. Beiträge Orthop Traumatol 1989; 36 (9): 424-428
8. Perhala SR, Wilke WS, Clough JD et al. Local infectious comlications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis and Rheumatism 1991; 34(2): 146-152
9. Rosandich PA, Kelley JT, Conn DL. Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers. Curr Opin Rheumatology 2004; 16(3): 192-198
10. Sany J, Anaya JM, Canovas F et al. Influence of Methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatology 1993; 20: 1129-1132
11. Arnett FC et al. The American Rheumatism Association 1987. Revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988; 31 (3): 315-324